Lupus is a category that has experienced lots of setbacks and disappointments, but the tide appears closer to turning than ever before given the large number of promising drugs for lupus advancing through the pipeline.
Scientific advancements and better understanding of the disease are helping to fuel the investment, but lupus also remains an autoimmune...






